AstraZeneca lupus drug meets main goal in study

AstraZeneca Plc said on Thursday its experimental drug to treat moderate-to-severe lupus, anifrolumab, met its main goal in a late-stage study.

from Reuters: Health News https://ift.tt/2ZsGnII
https://ift.tt/xePdMM